Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Poland

 

Interview: Stuart Fletcher, Chief Executive, Bupa

A year after Stuart “international growth opportunity” Fletcher took on the top job, where is he taking Bupa? The not-for-profit group offers insurance, hospitals, nursing homes, homecare and chronic disease management across the world. We talk to Fletcher about its recently-released results for 2012.

Report: How rating sites will change healthcare

TripAdvisor is changing how the travel industry treats customers. Is the same likely to happen to healthcare services? We look at the new review websites growing fast across Europe, propelled by expanding patient choice. What impact will they have on the profession and on private operators? Will they change the market?

Another facilities management company moves into soft outsourcing

Interserve, a construction and support services company quoted in the UK, has bought home healthcare provider Advantage Healthcare for £26.5m from Rutland Partners. The company already has sales of £300m in 2012 from the healthcare sector through facilities management. The move follows competitor MITIE’s purchase of domiciliary care provider Enara for £110.8m in October. We talk to Interserve director Robin O’Kelly to find out more.

Swissmed deal reveals how Bupa may change Poland

Polish hospital group Swissmed has sold the imaging department in its Gdansk hospital to Lux-Med, the largest private healthcare provider in Poland. Lux-Med is to be bought by international insurer Bupa, whilst this is the latest in a restructuring at Swissmed - but what does all this tell us about the Polish market?

Interview: Alison Platt, Managing Director, International Markets Development, Bupa

UK insurer Bupa has just bought Polish clinic chain Lux Med for £325m. The move means that an insurer now owns the largest Polish private healthcare provider. This is a sea change for a private healthcare market where insurers have always been weak outsiders, while the country has been dominated by a combination of private subscription healthcare providers and a black market in public healthcare services. We talk to Alison Platt, the managing director of Bupa’s international operations, about vertical integration.

FREE BLOG Kick up a fuss, review a doctor

Patients have mixed views of Zygmunt Dobrowolski, a urologist in Cracow, Poland. To one, he overcharges and thinks only of the money. To another, recovering from “girl frolics”, he is "very professional and witty". His 17 reviews garner him a lowly two stars out of five. That is a rating which, whether he knows it or not, is likely to have had a big impact on his wallet already.

Moonray expands ophthalmology with Lexum deal

Moonray Healthcare, the biomedical investment arm of Fidelity International, has added 10 ophthalmology centres to its network with the planned acquisition of Lexum from CEE specialist private equity house ARX Equity Investments. This follows the purchase of two centres in southern Germany from pan-Nordic player Memira, taking its network there to seven centres. We talk to Moonray CEO Tim Clover about the deal, and how Optegra grew like-for-like sales 35% in 2012 through presbyopia treatments.

Bupa plans vertical integration for Poland

Bupa is deadly serious about bidding for Lux-Med, the largest Polish subscription healthcare operator. But so are a couple of large private equity houses!

Medicover ownership is now not-for-profit

The majority of shares in Medicover - the East European healthcare group that owns lab chain Synevo - have been put into a charitable trust: the Jonas and Christina af Jochnick Foundation. Jonas af Jochnick, 75, is a kind of Swedish Bill Gates. What does this mean for the future of the group?

Find Us